New opportunities for RGD-engineered metal nanoparticles in cancer.

导出 OA

翻译打印收藏纠错

第一作者： Wei,Qin

第一单位： Xi'an Key Laboratory of Basic and Translation of Cardiovascular Metabolic Disease, College of Pharmacy, Xi'an Medical University, Xi'an, 710021, China.

作者： Wei,Qin ^[1] ; Jyoti,Chandra ^[2] ; Mohammed A S,Abourehab ^[3] ; Neelima,Gupta ^[4] ; Zhe-Sheng,Chen ^[5] ; Prashant,Kesharwani ^[6] ; Hui-Ling,Cao ^[7]

作者单位： Xi'an Key Laboratory of Basic and Translation of Cardiovascular Metabolic Disease, College of Pharmacy, Xi'an Medical University, Xi'an, 710021, China. ^[1] Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. ^[2] Department of Pharmaceutics, College of Pharmacy, Umm Al-Qura University, Makkah, 21955, Saudi Arabia. ^[3] Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, Madhya Pradesh, 470003, India. ^[4] Institute for Biotechnology, College of Pharmacy and Health Sciences, St. John's University, Queens, New York, 11439, USA. ^[5] Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India. prashantdops@gmail.com.;Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical science, Chennai, India. prashantdops@gmail.com. ^[6] Xi'an Key Laboratory of Basic and Translation of Cardiovascular Metabolic Disease, College of Pharmacy, Xi'an Medical University, Xi'an, 710021, China. caohuiling_jzs@xiyi.edu.cn. ^[7]

关键词 Cancer imaging Drug targeting Integrin Metal nanoparticles RGD cancer

主题词人类(Humans);肿瘤(Neoplasms);氨基酸序列(Amino Acid Sequence);甘氨酸(Glycine);金属纳米粒子(Metal Nanoparticles);寡肽类(Oligopeptides)

DOI 10.1186/s12943-023-01784-0

PMID 37226188

发布时间 2023-05-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交